We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals
TNXP

14 hedge funds and large institutions have $1.62M invested in Tonix Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

0% more ownership

Funds ownership: 0% → 0% (+0%)

22% less funds holding

Funds holding: 18 → 14 (-4)

64% less capital invested

Capital invested by funds: $4.51M → $1.62M (-$2.89M)

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
14
Holders Change
-4
Holders Change %
-22.22%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
7
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$98.5K
2
Bank of America
Bank of America
North Carolina
+$60.6K
3
TSS
Two Sigma Securities
New York
+$53.1K
4
Renaissance Technologies
Renaissance Technologies
New York
+$37.9K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$30.3K

Top Sellers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
-$650K
2
Morgan Stanley
Morgan Stanley
New York
-$250K
3
HFS
Hantz Financial Services
Michigan
-$51K
4
JP Morgan Chase
JP Morgan Chase
New York
-$37.9K
5
VF
Virtu Financial
New York
-$35K
Name Holding Trade Value Shares
Change 		Change in
Stake
NSIM
26
North Star Investment Management
Illinois
$11 – – –
GWSA
27
Global Wealth Strategies & Associates
Colorado
$5 – – –
IA
28
IFP Advisors
Florida
$5 – – –
HIA
29
Harbor Investment Advisory
Maryland
$2 – – –
TCM
30
Tradewinds Capital Management
Washington
$2 – – –
TLCM
31
Twin Lakes Capital Management
California
$2 – – –
TCM
32
Tang Capital Management
California
– -$650K -55 Closed
HFS
33
Hantz Financial Services
Michigan
– -$51K -4 Closed
VF
34
Virtu Financial
New York
– -$35K -3 Closed
SS
35
Simplicity Solutions
Minnesota
– -$21.7K -2 Closed
UBS Group
36
UBS Group
Switzerland
– -$15.2K -1 Closed
ASN
37
Advisory Services Network
Georgia
– -$1 – –
EDRH
38
Edmond de Rothschild Holding
Switzerland
– -$5.54K – –
Federated Hermes
39
Federated Hermes
Pennsylvania
– -$435 – –
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
– -$1 – –
1
2

TNXP Hedge Fund Activity: Q2 2023 in Review

14 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q2 2023, worth a combined $1.62M — down 64% from $4.51M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of TNXP and 1 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 7 added.

The largest buyer was Acadian Asset Management, adding an estimated $98.5K. The largest seller was Tang Capital Management, exiting entirely with an estimated $650K sold.

  • 14 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q2 2023, down from 18 in Q1 2023.
  • Funds reported $1.62M of Tonix Pharmaceuticals stock for Q2 2023, down 64% quarter-over-quarter.
  • 1 fund opened new Tonix Pharmaceuticals positions in Q2 2023 and 5 closed out, a net change of -4 holders.
  • The largest Tonix Pharmaceuticals buyer in Q2 2023 was Acadian Asset Management, an estimated $98.5K added.
  • The largest Tonix Pharmaceuticals seller in Q2 2023 was Tang Capital Management, an estimated $650K sold.

Based on aggregated 13F filings for Q2 2023.